Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Watchman21on Sep 25, 2021 10:39am
302 Views
Post# 33919025

FDA EUA Speed of Review in 1st 9 month…

FDA EUA Speed of Review in 1st 9 month…

More data on FDA & Volume of Covid tests they have reviewed and speed to approval.


It’s not a matter of months… more like days I believe, based on this data.

Since February 2020 through November 1, 2020 (9 months), the FDA used Emergency Use Authorization for over 285 diagnostic and serology Covid-19 tests.  That’s 9 months X 21 average work days per month is 189-190 work days at 285 tests.  That averages 1.5 per work day approved.  


I doubt we have that much more time to wait.  

Source:  
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/covid-19-test-development-and-review-faqs-testing-sars-cov-2Q: I submitted a pre-EUA or EUA request for a COVID-19 test. How long will the review take? (Updated 11/16/20)A: During this unprecedented public health emergency, the Agency has received an exceedingly high volume of EUA requests and is working as quickly as possible to review each request. There are hundreds of pre-EUA and EUA requests for COVID-19 tests under review and FDA continues to receive new submissions on a daily basis. To address this high volume of work, we have brought in additional scientific review staff to double the number of teams working on submissions; and we have implemented a triage program to prioritize submissions based on several factors. As a result of these efforts, by November 1, 2020, FDA had authorized over 285 diagnostic and serology tests, far exceeding the number of test EUAs issued during previous emergencies.

<< Previous
Bullboard Posts
Next >>